ENGINEEX LLC Information

ENGINEEX is a specialized consulting firm supporting pharmaceutical, biotechnology, CDMO, and specialty-medicine organizations with complex capital projects, GMP operational readiness, site transformation, issue resolution, and regulated manufacturing excellence. Built on 28+ years of global hands-on and executive industry experience, ENGINEEX helps organizations bring structure, urgency, and execution discipline to high-stakes GMP environments where safety, quality, compliance, schedule, cost, and business continuity must all be managed simultaneously. ENGINEEX operates with two core execution principles: RIGHT FIRST TIME and NO SURPRISES. Right First Time means disciplined planning, clear requirements, quality-by-design thinking, proactive risk management, and execution readiness before critical decisions or field activities move forward. No Surprises means transparent governance, early escalation, clear ownership, disciplined communication, and leadership visibility before issues become project, compliance, cost, or schedule risks. ENGINEEX supports capital project delivery, facility upgrades, shutdowns, operational readiness, CQV and validation alignment, quality/change-control planning, executive governance, risk management, site transitions, and complex issue resolution across regulated manufacturing environments. Representative experience includes: 20+ GMP manufacturing and CDMO sites supported worldwide $5B+ in asset value delivered and supported Strong regulatory readiness track record across FDA, EMA, PMDA, TGA, and ANVISA-regulated environments 28+ years of hands-on and executive pharma/biotech leadership experience ENGINEEX helps pharma and biotech organizations move complex projects from uncertainty to structure, from execution risk to operational readiness, and from fragmented activity to disciplined delivery — with Right First Time discipline and No Surprises execution.